Outlook Therapeutics (OTLK) EBIT (2015 - 2026)
Outlook Therapeutics (OTLK) recorded EBIT of -$10.81 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$15.75 million a year earlier.
Powered by 
Analysis
Outlook Therapeutics (OTLK) EBIT (2015 - 2026) Analysis & Trends
On a TTM basis, Outlook Therapeutics' EBIT came in at -$55.64 million as of Jun 30, 2026; for FY2025 (ended Sep 30, 2025), it was -$67.06 million.
- Across earlier fiscal years, EBIT came in at -$71.7 million in FY2024, -$53.13 million in FY2023, -$63.07 million in FY2022 and -$51.73 million in FY2021.
- The fiscal Q3 2026 figure is the highest quarterly EBIT since fiscal Q1 2024.
- Per Business Quant, the preceding three fiscal quarters came in at -$14.03 million (Q2 2026), -$13.48 million (Q1 2026) and -$17.31 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Outlook Therapeutics | 84.78 Mn | 49.03 Mn | -8,265.00 | -10.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.81 Mn |
| Mar 31, 2026 | -14.03 Mn |
| Dec 31, 2025 | -13.48 Mn |
| Sep 30, 2025 | -17.31 Mn |
| Jun 30, 2025 | -15.75 Mn |
| Mar 31, 2025 | -12.39 Mn |
| Dec 31, 2024 | -21.61 Mn |
| Sep 30, 2024 | -22.88 Mn |
| Jun 30, 2024 | -19.56 Mn |
| Mar 31, 2024 | -18.94 Mn |
| Dec 31, 2023 | -10.32 Mn |
| Sep 30, 2023 | -12.46 Mn |
| Jun 30, 2023 | -18.14 Mn |
| Mar 31, 2023 | -6.84 Mn |
| Dec 31, 2022 | -15.69 Mn |
| Sep 30, 2022 | -13.99 Mn |
| Jun 30, 2022 | -17.02 Mn |
| Mar 31, 2022 | -18.91 Mn |
| Dec 31, 2021 | -13.15 Mn |
| Sep 30, 2021 | -13.44 Mn |
API Access
Outlook Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();